Skip to content
MarketScale
‹ Back to IndustriesEngineering & Construction

GM Undershoots Estimates on Chip Dearth, Lifts Full-Year Outlook

(Bloomberg) — General Motors Co. missed analysts’ profit estimates for the latest quarter but raised its full-year guidance as rich margins on pickups vied with nagging production cuts at its North American factories from a global semiconductor shortage. Soaring new-vehicle prices on high-margin pickups couldn’t make up for supply chain issues in the second quarter…

This story was produced through MarketScale. See how Engineering & Construction teams put it to work with Partner & Channel Enablement.

Share
GM Undershoots Estimates on Chip Dearth, Lifts Full-Year Outlook

Get featured

Want MarketScale to feature Engineering & Construction?

Book a 15-minute demo and we'll map your Engineering & Construction expertise to the content buyers are searching for.

Book a demo

(Bloomberg) — General Motors Co. missed analysts’ profit estimates for the latest quarter but raised its full-year guidance as rich margins on pickups vied with nagging production cuts at its North American factories from a global semiconductor shortage.

Soaring new-vehicle prices on high-margin pickups couldn’t make up for supply chain issues in the second quarter and expenses related to battery fires on its Chevrolet Bolt electric vehicle. But GM remained optimistic about its full-year earnings prospects, boosting its 2021 forecast Wednesday after signaling in June it would hit the high-end of its previous guidance.

The Detroit automaker now expects adjusted earnings before interest and taxes of $11.5 billion to $13 billion for all of 2021, which translates to adjusted earnings of $5.40 to $6.40 per share. That compares to an earlier projection for $10 billion to $11 billion, or $4.50 to $5.25 a share.

Shares of GM fell 2.9% in premarket trading to $56.20 as of 7:45 a.m. in New York. The stock had gained 39% this year as of the close Tuesday.

Chip Shortfall

Record average transaction prices for new vehicles pumped up profits, even as GM and other automakers struggled to keep plants open due to shortfalls in chip supplies. The company’s average new vehicle transaction price in July rose 9% from a year earlier — almost double the industry average of 4.8% — to an estimated $44,749, according to market researcher TrueCar.

But it hasn’t been able to make the most of that uptick in pricing due to limited vehicle inventories. GM disclosed on Tuesday that output of its Chevrolet Silverado and GMC Sierra full-size pickups — which it sold a combined 237,000 of last quarter — would be affected by another round of temporary factory closures in Michigan and Mexico through Aug. 16.

The automaker reported adjusted earnings per share of $1.97 for the second quarter, below the $2.08 a share analyst consensus forecast compiled by Bloomberg. That compares to a 50 cents a share adjusted loss a year ago while in the grips of the pandemic and the 13 cents a share archrival Ford Motor Co. posted last week for the latest quarter.

GM said it spent $800 million on a recall issued late last month for almost 69,000 Chevy Bolts due to the risk of fires from defective batteries made by South Korea’s LG Chem Ltd.

More stories like this are available on bloomberg.com

©2021 Bloomberg L.P.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Engineering & Construction starts with a company putting its project engineers, superintendents, and estimators on the record. Buyers are already reading this topic. The only question is whose experts they find.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Engineering & Construction Insights

Get new expert content in your inbox.

Engineering & Construction: are you visible to AI?

Before they reach out, Engineering & Construction buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Engineering & Construction expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your project engineers, superintendents, and estimators into the articles, video, and social content Engineering & Construction buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Engineering & Construction Insights

Procore acquires DroneDeploy for $845M, giving construction teams a direct line from drone data to project management

Procore acquires DroneDeploy for $845M, giving construction teams a direct line from drone data to project management

Procore has acquired DroneDeploy for $845 million, enhancing its construction project management capabilities. This acquisition integrates drone-based reality capture data with Procore's project management tools, streamlining the workflow between site data capture and management. The integration aims to improve efficiency and reduce gaps in construction project workflows.

  • 01Procore acquired DroneDeploy for $845 million.
  • 02The acquisition integrates drone data directly into construction project management.
  • 03This integration is expected to improve construction project efficiency and reduce data workflow gaps.

Aug 7, 2026

What Challenges Are Manufacturers Facing Under Annex 1?

What Challenges Are Manufacturers Facing Under Annex 1?

Manufacturers are facing significant challenges under Annex 1, which regulates sterile production processes. Compliance with these regulations is critical for maintaining product safety and quality. Identifying potential risks and implementing effective control measures are key aspects for manufacturers to address.

  • 01Annex 1 presents challenges in maintaining sterile production processes for manufacturers.
  • 02Compliance with Annex 1 regulations is crucial for product safety and quality.
  • 03Manufacturers must identify risks and implement effective control measures.

Aug 3, 2026

What Are the Biggest Challenges Pharmaceutical Manufacturers Are Facing Today?

What Are the Biggest Challenges Pharmaceutical Manufacturers Are Facing Today?

Pharmaceutical manufacturers face significant challenges such as ensuring quality control, navigating regulatory requirements, and managing supply chain disruptions. These issues are intensified by the need for innovation and rapid response to market demands. Companies must balance these factors to remain competitive in the industry.

  • 01Quality control is a major challenge for pharmaceutical manufacturers.
  • 02Regulatory compliance is essential but can be complex and time-consuming.
  • 03Supply chain disruptions require strategic management and contingency planning.

Aug 3, 2026

Explore More Engineering & Construction Insights

Read more expert perspectives from across Engineering & Construction.

Browse Engineering & Construction Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Engineering & Construction and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512